GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (FRA:PDXN) » Definitions » Revenue

Pro-Dex (FRA:PDXN) Revenue : €45.70 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pro-Dex Revenue?

Pro-Dex's revenue for the three months ended in Mar. 2024 was €13.15 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €45.70 Mil. Pro-Dex's Revenue per Share for the three months ended in Mar. 2024 was €3.73. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €12.83.

Warning Sign:

Pro-Dex Inc revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Pro-Dex was 6.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 19.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Pro-Dex's highest 3-Year average Revenue per Share Growth Rate was 23.20% per year. The lowest was -25.70% per year. And the median was 4.40% per year.


Pro-Dex Revenue Historical Data

The historical data trend for Pro-Dex's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex Revenue Chart

Pro-Dex Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.05 30.93 31.56 39.77 42.54

Pro-Dex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.22 9.82 11.19 11.54 13.15

Competitive Comparison of Pro-Dex's Revenue

For the Medical Instruments & Supplies subindustry, Pro-Dex's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro-Dex's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Revenue distribution charts can be found below:

* The bar in red indicates where Pro-Dex's Revenue falls into.



Pro-Dex Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €45.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro-Dex  (FRA:PDXN) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Pro-Dex Revenue Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro-Dex (FRA:PDXN) Business Description

Traded in Other Exchanges
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Pro-Dex (FRA:PDXN) Headlines

No Headlines